Table 1: Clinical parameters
| Characteristic | Fatty liver (n = 5) | Nonalcoholic steatohepatitis (n = 10) | Statistical significance | ||||
| Age, years | 38 ± 17 | 62±9 | < 0.05* | ||||
| Gender (males/females) | 4/1 | 3/7 | |||||
| Body mass index (kg/m2) | 25.9 ± 3.5 | 26.5 ± 3.0 | NS | ||||
| Albumin (g/dL) | 4.8 ± 0.4 | 4.5 ± 0.6 | NS | ||||
| Total bilirubin (mg/dL) | 1.1 ± 0.9 | 0.8 ± 0.2 | NS | ||||
| Aspartate transaminase (U/l) | 59.4 ± 25.4 | 63.6 ± 39.5 | NS | ||||
| Alanine transaminase (U/l) | 146 ± 87 | 125 ± 74 | NS | ||||
| Alkaline phosphatase (U/l) | 298 ± 51 | 306 ± 172 | NS | ||||
| γ-Glutamyltranspeptidase (U/l) | 97 ± 65 | 120 ± 75 | NS | ||||
| Total cholesterol (mg/dL) | 228 ± 50 | 225 ± 47 | NS | ||||
| Triglycerides (mg/dL) | 132 ± 24 | 184 ± 112 | NS | ||||
| Glucose (mg/dL) | 103 ± 5.6 | 142 ± 43 | NS | ||||
| HbA1c (%) | 5.6 ± 1.6 | 6.8 ± 1.2 | < 0.05* | ||||
| Insulin (μU/mL) | 17 ± 4 | 18 ± 15 | NS | ||||
| HOMA-R | 4.2 ± 0.9 | 6.1 ± 6.0 | NS | ||||
| Ferritin (ng/mL) | 225 ± 77 | 243 ± 124 | NS | ||||
| Hyaluronic acid (ng/mL) | 12 ± 2 | 81 ± 60 | < 0.05* |
All data expressed as the mean ± SD. p value calculated using Student t-test. NS: Not significant; HbA1c: Glycosylated hemoglobin; HOMA-R: Homeostasis model assessment insulin resistance.
*Statistical difference between the fatty liver and nonalcoholic steatohepatitis.